Papers in Scientific Journals (4)
Castro V. I. B., Amorim S., Caballero D., Abreu C. M., Kundu S. C., Reis R. L., Pashkuleva I., and Pires R. A.,
"Patterned glycopeptide-based supramolecular hydrogel promotes the alignment and contractility of iPSC-derived cardiomyocytes",
Biomaterials Advances, vol. 167, pp. 214091, doi:
10.1016/j.bioadv.2024.214091, 2025.
Caballero D., Lima A. C., Abreu C. M., Neves N. M., Correlo V. M., Oliveira J. M., Reis R. L., and Kundu S. C.,
"Quantifying protrusions as tumor-specific biophysical predictors of cancer invasion in in vitro tumor micro-spheroid models",
In Vitro Models, vol. 1, pp. 1-11, doi:
10.1007/s44164-022-00020-1, 2022.
Caballero D., Brancato V., Lima, Ana C., Abreu C. M., Neves N. M., Correlo V. M., Oliveira J. M., Reis R. L., and Kundu S. C.,
"Tumor-Associated Protrusion Fluctuations as a Signature of Cancer Invasiveness",
Advanced Biology, pp. 2101019, doi:
10.1002/adbi.202101019, 2021.
Oliveira I. M., Carvalho M. R., Fernandes D. C., Abreu C. M., Maia F. R., Pereira H., Caballero D., Kundu S. C., Reis R. L., and Oliveira J. M.,
"Modulation of inflammation by anti-TNF α mAb-dendrimer nanoparticles loaded in tyramine-modified gellan gum hydrogels in a cartilage-on-a-chip model",
Journal Of Materials Chemistry B, doi:
10.1039/D1TB00802A, 2021.
Review Paper (2)
Abreu C. M., Costa-Silva B., Reis R. L., Kundu S. C., and Caballero D.,
"Microfluidic platforms for extracellular vesicle isolation, analysis and therapy in cancer",
Lab on a Chip, vol. 22, pp. 1093-1125, doi:
10.1039/D2LC00006G, 2022.
Caballero D., Abreu C. M., Lima, Ana C., Neves N. M., Reis R. L., and Kundu S. C.,
"Precision biomaterials in cancer theranostics and modelling",
Biomaterials, vol. 280, pp. 121299, doi:
10.1016/j.biomaterials.2021.121299, 2021.
Book Chapter (4)
Caballero D., Abreu C. M., Carvalho M. R., Oliveira J. M., Reis R. L., and Kundu S. C.,
"Microfluidic engineering of silk fibroin biomateria",
Silk-Based Biomaterials for Tissue Engineering, Regenerative and Precision Medicine,
Eds. Reis R. L., and Kundu S. C.,
Elsevier, 2, vol. 1, pp. 746, doi:
10.1016/B978-0-323-96017-5.00011-X, 2023.
Caballero D., Abreu C. M., Reis R. L., and Kundu S. C.,
"Emerging Microfluidic and Biosensor Technologies for Improved Cancer Theranostics",
Microfluidics and Biosensors in Cancer Research. Advances in Experimental Medicine and Biology,
Eds. Caballero D., Kundu S. C., and Reis R. L.,
Springer, 1, vol. 1379, pp. 461-495, doi:
0.1007/978-3-031-04039-9_19, 2022.
Abreu C. M., Caballero D., Kundu S. C., and Reis R. L.,
"From Exosomes to Circulating Tumor Cells: Using Microfluidics to Detect High Predictive Cancer Biomarkers",
Microfluidics and Biosensors in Cancer Research,
Eds. Caballero D., Kundu S. C., and Reis R. L.,
Springer, vol. 1379, pp. 369–387, doi:
10.1007/978-3-031-04039-9_15, 2022.
Kundu B., Caballero D., Abreu C. M., Reis R. L., and Kundu S. C.,
"The Tumor Microenvironment: An Introduction to the Development of Microfluidic Devices",
Microfluidics and Biosensors in Cancer Research. Advances in Experimental Medicine and Biology,
Eds. Caballero D., Kundu S. C., and Reis R. L.,
Springer, 1, vol. 1379, pp. 115–138, doi:
10.1007/978-3-031-04039-9_5, 2022.
Invited Review Paper (1)
Caballero D., Kundu B., Abreu C. M., Amorim S., Fernandes D. C., Pires R. A., Oliveira J. M., Correlo V. M., Reis R. L., and Kundu S. C.,
"Forecast cancer: the importance of biomimetic 3D in vitro models in cancer drug testing/discovery and therapy",
In Vitro Models, vol. 2, doi:
10.1007/s44164-022-00014-z, 2022.
Comunications - Poster (1)
Comunication - Oral (5)
Caballero D., Abreu C. M., Lima A. C., Brancato V., Neves N. M., Correlo V. M., Oliveira J. M., Reis R. L., and Kundu S. C.,
"Protrusion Fluctuations as a Predictive Morphodynamic Signature of Tumor Invasion",
Final FoReCaST conference, 2021.
Caballero D., Brancato V., Lima, Ana C., Abreu C. M., Neves N. M., Correlo V. M., Oliveira J. M., Reis R. L., and Kundu S. C.,
"Tumor-Associated Protrusion Fluctuations as a Signature of Breast Cancer Invasiveness",
3rd FoReCaST workshop, 2021.